11. Preparation of 4-benzimidazolyl-2-morpholino-6-piperidinyl-4-pyrimidine derivatives as PI3K and mTOR kinase inhibitors for the treatment

12. Preparation of 4-benzimidazolyl-2-morpholino-6-piperazinyl-pyrimidine derivatives as PI3K and mTOR kinase inhibitors for the treatment

13. Preparation of 2-benzimidazolyl-6-morpholino-4-phenylpyrimidine derivatives as PI3K and mTOR inhibitors for treatment of proliferative

14. Preparation of 2-benzimidazolyl-6-morpholino-4-heterocyclylpyrimidine derivatives as PI3K and mTOR inhibitors for treatment of proliferative

15. Preparation of 2-benzimidazolyl-6-morpholino-4-(piperidin-4-yl)pyrimidine derivatives as PI3K and mTOR inhibitors for treatment of proliferative

16. Preparation of acylamino dibenzothiophenes as DNA-PK inhibitors Frigerio, Mark; Hummersone, Marc Geoffrey; Menear,

17. Pyrimidine derivatives as EphB4 inhibitors and their preparation, pharmaceutical compositions and use in

18. Sulfonamide derivatives for therapeutic use as fatty acid synthase inhibitors Butlin, R. J.;

19. Piperidine derivatives for the treatment of obesity Butlin, R. J.; Caulkett, P. W.

20. Piperidine derivatives for the treatment of obesity Butlin, R. J.; Caulkett, P. W.